 Historic aspects intravenous immunoglobulin therapy preparations immunoglobulins Ig susceptibility agammaglobulinemic patients infections pneumococci Haemophilus influenzae meningococci streptococci Pseudomonas aeruginosa Intramuscular administration preparations painful traumatic children Ethanol-fractionated Ig IV IgG molecules likely anaphylactoid reactions New Ig preparations low pH pH presence traces pepsin reaggregation IV new era treatment prophylaxis disease IV Ig IVIG IVIG preparations management immunodeficiency syndromes failure antibody responses Amelioration antibody deficiency secondary certain chronic diseases surgical trauma preparations Newer IVIG treatment autoimmune diseases conditions beneficial influences attributable antibodies present IVIG likely explanation IVIG damage cells tissues antibody-mediated cellular cytotoxicity blocks phagocytosis Fc receptor mechanisms value IVIG infection patients bone marrow organ transplantation treatment prophylaxis life-threatening infections neonates premature infants